These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 26212366)
1. Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors. El-labbad EM; Ismail MA; Abou Ei Ella DA; Ahmed M; Wang F; Barakat KH; Abouzid KA Chem Biol Drug Des; 2015 Dec; 86(6):1518-27. PubMed ID: 26212366 [TBL] [Abstract][Full Text] [Related]
2. Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease. Dhindwal S; Kesari P; Singh H; Kumar P; Tomar S J Biomol Struct Dyn; 2017 Dec; 35(16):3522-3539. PubMed ID: 27844505 [TBL] [Abstract][Full Text] [Related]
3. Design and Validation of Novel Chikungunya Virus Protease Inhibitors. Das PK; Puusepp L; Varghese FS; Utt A; Ahola T; Kananovich DG; Lopp M; Merits A; Karelson M Antimicrob Agents Chemother; 2016 Dec; 60(12):7382-7395. PubMed ID: 27736770 [TBL] [Abstract][Full Text] [Related]
4. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents. Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048 [TBL] [Abstract][Full Text] [Related]
5. Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease. Singh H; Mudgal R; Narwal M; Kaur R; Singh VA; Malik A; Chaudhary M; Tomar S Biochimie; 2018 Jun; 149():51-61. PubMed ID: 29635044 [TBL] [Abstract][Full Text] [Related]
7. Thiazolidone derivatives as inhibitors of chikungunya virus. Jadav SS; Sinha BN; Hilgenfeld R; Pastorino B; de Lamballerie X; Jayaprakash V Eur J Med Chem; 2015 Jan; 89():172-8. PubMed ID: 25462237 [TBL] [Abstract][Full Text] [Related]
8. Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus. Bassetto M; De Burghgraeve T; Delang L; Massarotti A; Coluccia A; Zonta N; Gatti V; Colombano G; Sorba G; Silvestri R; Tron GC; Neyts J; Leyssen P; Brancale A Antiviral Res; 2013 Apr; 98(1):12-8. PubMed ID: 23380636 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus. Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511 [TBL] [Abstract][Full Text] [Related]
10. Inhibitor of the non-structural protein 2 protease shows promising efficacy in mouse models of chikungunya. Metibemu DS; Adeyinka OS; Falode J; Hampton T; Crown O; Ojobor JC; Narayanan A; Julander J; Ogungbe IV Eur J Med Chem; 2024 Nov; 278():116808. PubMed ID: 39236495 [TBL] [Abstract][Full Text] [Related]
11. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya. Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines. Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication. Di Mola A; Peduto A; La Gatta A; Delang L; Pastorino B; Neyts J; Leyssen P; de Rosa M; Filosa R Bioorg Med Chem; 2014 Nov; 22(21):6014-25. PubMed ID: 25282648 [TBL] [Abstract][Full Text] [Related]